APO Research
Talk to an analyst

APO RESEARCH · REPORT

Serum and Plasma Proteomics Service

Compare research editions
View pricing & licenses

Selected research

Industry Research

Serum and Plasma Proteomics Service Industry Research Report 2026

12 August 2026143 pages

Choose your research edition.

Industry ResearchSerum and Plasma Proteomics Service Industry Research Report 2026143 pages · $2,950 USDIndustry Growth & TrendsGlobal Serum and Plasma Proteomics Service Industry Growth and Trends Forecast to 2032120 pages · $3,450 USDMarket StructureGlobal Serum and Plasma Proteomics Service Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Serum and Plasma Proteomics Service Market Outlook and Growth Opportunities 2026213 pages · $4,250 USDMarket Analysis & ForecastGlobal Serum and Plasma Proteomics Service Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

The global Serum and Plasma Proteomics Service market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.

North America: the Serum and Plasma Proteomics Service market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Serum and Plasma Proteomics Service market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Serum and Plasma Proteomics Service market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Serum and Plasma Proteomics Service include BostonGene, CellCarta, GENEWIZ (Azenta Life Sciences), CDI Labs, Biognosys, Discovery Life Sciences, Firalis Molecular Precision, Cell Signaling Technology (CST) and Sampled (Infinity Biologix), among others; in 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

Read the full market overview

This report quantifies the global Serum and Plasma Proteomics Service market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.

It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Serum and Plasma Proteomics Service.

Key Companies & Market Share Insights

This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.

Serum and Plasma Proteomics Service Market by Company

BostonGene

CellCarta

GENEWIZ (Azenta Life Sciences)

CDI Labs

Biognosys

Discovery Life Sciences

Firalis Molecular Precision

Cell Signaling Technology (CST)

Sampled (Infinity Biologix)

APTBIO

Sinotech Genomics

Biodesix

Panome Bio

Novogene

PTM BIO

BGI Genomics

Evotec

Metware Biotechnology

MRM Proteomics

Lc-Bio Technologies

Eurofins Scientific

MtoZ-Biolabs

Creative Proteomics

Macrogen

TATAA Biocenter

OmicScouts (Momentum Biotechnologies)

Precision Biomarker Laboratories (PBL)

Shanghai OE Biotech

RxCelerate

Proteomics International

Proteome Sciences

Westlake Omics

Crown Bioscience

VProteomics

Shanghai Majorbio Bio-Pharm

Applied Biomics

Sapient Bioanalytics

Allumiqs

MS Bioworks

Shanghai Bioprofile

Cosmos Wisdom

Olink (Thermo Fisher Scientific)

SomaLogic (Illumina)

Labcorp

Serum and Plasma Proteomics Service Segment by Type

Plasma Proteomics Analysis Service

Serum Proteomics Analysis Service

Serum and Plasma Proteomics Service Segment by Application

Disease Biomarker Research

Drug Development

Clinical Research

Others

Serum and Plasma Proteomics Service Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Spain

Russia

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Saudi Arabia

Israel

United Arab Emirates

Turkey

Iran

Egypt

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Serum and Plasma Proteomics Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Serum and Plasma Proteomics Service and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Serum and Plasma Proteomics Service.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.

Chapter 6: Detailed analysis of Serum and Plasma Proteomics Service companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 13: The main points and conclusions of the report.

More report detail

Tables and figures
List of Tables Table 1. Secondary Sources Table 2. Primary Sources Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Serum and Plasma Proteomics Service Market Size by Type (2021-2026) & (US$ Million) Table 6. Global Serum and Plasma Proteomics Service Revenue Market Share by Type (2021-2026) Table 7. Global Serum and Plasma Proteomics Service Forecasted Market Size by Type (2027-2032) & (US$ Million) Table 8. Global Serum and Plasma Proteomics Service Revenue Market Share by Type (2027-2032) Table 9. Global Serum and Plasma Proteomics Service Market Size by Application (2021-2026) & (US$ Million) Table 10. Global Serum and Plasma Proteomics Service Revenue Market Share by Application (2021-2026) Table 11. Global Serum and Plasma Proteomics Service Forecasted Market Size by Application (2027-2032) & (US$ Million) Table 12. Global Serum and Plasma Proteomics Service Revenue Market Share by Application (2027-2032) Table 13. Global Serum and Plasma Proteomics Service Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Table 14. Global Serum and Plasma Proteomics Service Market Size by Region (2021-2026) & (US$ Million) Table 15. Global Serum and Plasma Proteomics Service Market Share by Region (2021-2026) Table 16. Global Serum and Plasma Proteomics Service Forecasted Market Size by Region (2027-2032) & (US$ Million) Table 17. Global Serum and Plasma Proteomics Service Market Share by Region (2027-2032) Table 18. Serum and Plasma Proteomics Service Industry Trends Table 19. Serum and Plasma Proteomics Service Industry Drivers Table 20. Serum and Plasma Proteomics Service Industry Opportunities and Challenges Table 21. Serum and Plasma Proteomics Service Market Restraints Table 22. Global Top Serum and Plasma Proteomics Service Players by Revenue (US$ Million) & (2021-2026) Table 23. Global Serum and Plasma Proteomics Service Revenue Market Share by Players (2021-2026) Table 24. Global Serum and Plasma Proteomics Service Industry Players Ranking, 2024 VS 2025 VS 2026 Table 25. Global Key Players of Serum and Plasma Proteomics Service, Headquarters and Area Served Table 26. Global Serum and Plasma Proteomics Service Players, Product Type & Application Table 27. Global Players Market Concentration Ratio (CR5 and HHI) Table 28. Global Serum and Plasma Proteomics Service by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 29. Players Mergers & Acquisitions, Expansion Plans Table 30. North America Serum and Plasma Proteomics Service Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 31. North America Serum and Plasma Proteomics Service Market Size by Country (2021-2026) & (US$ Million) Table 32. North America Serum and Plasma Proteomics Service Market Size by Country (2027-2032) & (US$ Million) Table 33. Europe Serum and Plasma Proteomics Service Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 34. Europe Serum and Plasma Proteomics Service Market Size by Country (2021-2026) & (US$ Million) Table 35. Europe Serum and Plasma Proteomics Service Market Size by Country (2027-2032) & (US$ Million) Table 36. Asia Pacific Serum and Plasma Proteomics Service Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 37. Asia Pacific Serum and Plasma Proteomics Service Market Size by Region (2021-2026) & (US$ Million) Table 38. Asia Pacific Serum and Plasma Proteomics Service Market Size by Country (2027-2032) & (US$ Million) Table 39. South America Serum and Plasma Proteomics Service Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 40. South America Serum and Plasma Proteomics Service Market Size by Country (2021-2026) & (US$ Million) Table 41. South America Serum and Plasma Proteomics Service Market Size by Country (2027-2032) & (US$ Million) Table 42. Middle East & Africa Serum and Plasma Proteomics Service Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 43. Middle East & Africa Serum and Plasma Proteomics Service Market Size by Country (2021-2026) & (US$ Million) Table 44. Middle East & Africa Serum and Plasma Proteomics Service Market Size by Country (2027-2032) & (US$ Million) Table 45. BostonGene Company Information Table 46. BostonGene Business Overview Table 47. BostonGene Revenue in Serum and Plasma Proteomics Service Business (2021-2026) & (US$ Million) Table 48. BostonGene Serum and Plasma Proteomics Service Product Portfolio Table 49. BostonGene Recent Developments Table 50. CellCarta Company Information Table 51. CellCarta Business Overview Table 52. CellCarta Revenue in Serum and Plasma Proteomics Service Business (2021-2026) & (US$ Million) Table 53. CellCarta Serum and Plasma Proteomics Service Product Portfolio Table 54. CellCarta Recent Developments Table 55. GENEWIZ (Azenta Life Sciences) Company Information Table 56. GENEWIZ (Azenta Life Sciences) Business Overview Table 57. GENEWIZ (Azenta Life Sciences) Revenue in Serum and Plasma Proteomics Service Business (2021-2026) & (US$ Million) Table 58. GENEWIZ (Azenta Life Sciences) Serum and Plasma Proteomics Service Product Portfolio Table 59. GENEWIZ (Azenta Life Sciences) Recent Developments Table 60. CDI Labs Company Information Table 61. CDI Labs Business Overview Table 62. CDI Labs Revenue in Serum and Plasma Proteomics Service Business (2021-2026) & (US$ Million) Table 63. CDI Labs Serum and Plasma Proteomics Service Product Portfolio Table 64. CDI Labs Recent Developments Table 65. Biognosys Company Information Table 66. Biognosys Business Overview Table 67. Biognosys Revenue in Serum and Plasma Proteomics Service Business (2021-2026) & (US$ Million) Table 68. Biognosys Serum and Plasma Proteomics Service Product Portfolio Table 69. Biognosys Recent Developments Table 70. Discovery Life Sciences Company Information Table 71. Discovery Life Sciences Business Overview Table 72. Discovery Life Sciences Revenue in Serum and Plasma Proteomics Service Business (2021-2026) & (US$ Million) Table 73. Discovery Life Sciences Serum and Plasma Proteomics Service Product Portfolio Table 74. Discovery Life Sciences Recent Developments Table 75. Firalis Molecular Precision Company Information Table 76. Firalis Molecular Precision Business Overview Table 77. Firalis Molecular Precision Revenue in Serum and Plasma Proteomics Service Business (2021-2026) & (US$ Million) Table 78. Firalis Molecular Precision Serum and Plasma Proteomics Service Product Portfolio Table 79. Firalis Molecular Precision Recent Developments Table 80. Cell Signaling Technology (CST) Company Information Table 81. Cell Signaling Technology (CST) Business Overview Table 82. Cell Signaling Technology (CST) Revenue in Serum and Plasma Proteomics Service Business (2021-2026) & (US$ Million) Table 83. Cell Signaling Technology (CST) Serum and Plasma Proteomics Service Product Portfolio Table 84. Cell Signaling Technology (CST) Recent Developments Table 85. Sampled (Infinity Biologix) Company Information Table 86. Sampled (Infinity Biologix) Business Overview Table 87. Sampled (Infinity Biologix) Revenue in Serum and Plasma Proteomics Service Business (2021-2026) & (US$ Million) Table 88. Sampled (Infinity Biologix) Serum and Plasma Proteomics Service Product Portfolio Table 89. Sampled (Infinity Biologix) Recent Developments Table 90. APTBIO Company Information Table 91. APTBIO Business Overview Table 92. APTBIO Revenue in Serum and Plasma Proteomics Service Business (2021-2026) & (US$ Million) Table 93. APTBIO Serum and Plasma Proteomics Service Product Portfolio Table 94. APTBIO Recent Developments Table 95. Sinotech Genomics Company Information Table 96. Sinotech Genomics Business Overview Table 97. Sinotech Genomics Revenue in Serum and Plasma Proteomics Service Business (2021-2026) & (US$ Million) Table 98. Sinotech Genomics Serum and Plasma Proteomics Service Product Portfolio Table 99. Sinotech Genomics Recent Developments Table 100. Biodesix Company Information Table 101. Biodesix Business Overview Table 102. Biodesix Revenue in Serum and Plasma Proteomics Service Business (2021-2026) & (US$ Million) Table 103. Biodesix Serum and Plasma Proteomics Service Product Portfolio Table 104. Biodesix Recent Developments Table 105. Panome Bio Company Information Table 106. Panome Bio Business Overview Table 107. Panome Bio Revenue in Serum and Plasma Proteomics Service Business (2021-2026) & (US$ Million) Table 108. Panome Bio Serum and Plasma Proteomics Service Product Portfolio Table 109. Panome Bio Recent Developments Table 110. Novogene Company Information Table 111. Novogene Business Overview Table 112. Novogene Revenue in Serum and Plasma Proteomics Service Business (2021-2026) & (US$ Million) Table 113. Novogene Serum and Plasma Proteomics Service Product Portfolio Table 114. Novogene Recent Developments Table 115. PTM BIO Company Information Table 116. PTM BIO Business Overview Table 117. PTM BIO Revenue in Serum and Plasma Proteomics Service Business (2021-2026) & (US$ Million) Table 118. PTM BIO Serum and Plasma Proteomics Service Product Portfolio Table 119. PTM BIO Recent Developments Table 120. BGI Genomics Company Information Table 121. BGI Genomics Business Overview Table 122. BGI Genomics Revenue in Serum and Plasma Proteomics Service Business (2021-2026) & (US$ Million) Table 123. BGI Genomics Serum and Plasma Proteomics Service Product Portfolio Table 124. BGI Genomics Recent Developments Table 125. Evotec Company Information Table 126. Evotec Business Overview Table 127. Evotec Revenue in Serum and Plasma Proteomics Service Business (2021-2026) & (US$ Million) Table 128. Evotec Serum and Plasma Proteomics Service Product Portfolio Table 129. Evotec Recent Developments Table 130. Metware Biotechnology Company Information Table 131. Metware Biotechnology Business Overview Table 132. Metware Biotechnology Revenue in Serum and Plasma Proteomics Service Business (2021-2026) & (US$ Million) Table 133. Metware Biotechnology Serum and Plasma Proteomics Service Product Portfolio Table 134. Metware Biotechnology Recent Developments Table 135. MRM Proteomics Company Information Table 136. MRM Proteomics Business Overview Table 137. MRM Proteomics Revenue in Serum and Plasma Proteomics Service Business (2021-2026) & (US$ Million) Table 138. MRM Proteomics Serum and Plasma Proteomics Service Product Portfolio Table 139. MRM Proteomics Recent Developments Table 140. Lc-Bio Technologies Company Information Table 141. Lc-Bio Technologies Business Overview Table 142. Lc-Bio Technologies Revenue in Serum and Plasma Proteomics Service Business (2021-2026) & (US$ Million) Table 143. Lc-Bio Technologies Serum and Plasma Proteomics Service Product Portfolio Table 144. Lc-Bio Technologies Recent Developments Table 145. Eurofins Scientific Company Information Table 146. Eurofins Scientific Business Overview Table 147. Eurofins Scientific Revenue in Serum and Plasma Proteomics Service Business (2021-2026) & (US$ Million) Table 148. Eurofins Scientific Serum and Plasma Proteomics Service Product Portfolio Table 149. Eurofins Scientific Recent Developments Table 150. MtoZ-Biolabs Company Information Table 151. MtoZ-Biolabs Business Overview Table 152. MtoZ-Biolabs Revenue in Serum and Plasma Proteomics Service Business (2021-2026) & (US$ Million) Table 153. MtoZ-Biolabs Serum and Plasma Proteomics Service Product Portfolio Table 154. MtoZ-Biolabs Recent Developments Table 155. Creative Proteomics Company Information Table 156. Creative Proteomics Business Overview Table 157. Creative Proteomics Revenue in Serum and Plasma Proteomics Service Business (2021-2026) & (US$ Million) Table 158. Creative Proteomics Serum and Plasma Proteomics Service Product Portfolio Table 159. Creative Proteomics Recent Developments Table 160. Macrogen Company Information Table 161. Macrogen Business Overview Table 162. Macrogen Revenue in Serum and Plasma Proteomics Service Business (2021-2026) & (US$ Million) Table 163. Macrogen Serum and Plasma Proteomics Service Product Portfolio Table 164. Macrogen Recent Developments Table 165. TATAA Biocenter Company Information Table 166. TATAA Biocenter Business Overview Table 167. TATAA Biocenter Revenue in Serum and Plasma Proteomics Service Business (2021-2026) & (US$ Million) Table 168. TATAA Biocenter Serum and Plasma Proteomics Service Product Portfolio Table 169. TATAA Biocenter Recent Developments Table 170. OmicScouts (Momentum Biotechnologies) Company Information Table 171. OmicScouts (Momentum Biotechnologies) Business Overview Table 172. OmicScouts (Momentum Biotechnologies) Revenue in Serum and Plasma Proteomics Service Business (2021-2026) & (US$ Million) Table 173. OmicScouts (Momentum Biotechnologies) Serum and Plasma Proteomics Service Product Portfolio Table 174. OmicScouts (Momentum Biotechnologies) Recent Developments Table 175. Precision Biomarker Laboratories (PBL) Company Information Table 176. Precision Biomarker Laboratories (PBL) Business Overview Table 177. Precision Biomarker Laboratories (PBL) Revenue in Serum and Plasma Proteomics Service Business (2021-2026) & (US$ Million) Table 178. Precision Biomarker Laboratories (PBL) Serum and Plasma Proteomics Service Product Portfolio Table 179. Precision Biomarker Laboratories (PBL) Recent Developments Table 180. Shanghai OE Biotech Company Information Table 181. Shanghai OE Biotech Business Overview Table 182. Shanghai OE Biotech Revenue in Serum and Plasma Proteomics Service Business (2021-2026) & (US$ Million) Table 183. Shanghai OE Biotech Serum and Plasma Proteomics Service Product Portfolio Table 184. Shanghai OE Biotech Recent Developments Table 185. RxCelerate Company Information Table 186. RxCelerate Business Overview Table 187. RxCelerate Revenue in Serum and Plasma Proteomics Service Business (2021-2026) & (US$ Million) Table 188. RxCelerate Serum and Plasma Proteomics Service Product Portfolio Table 189. RxCelerate Recent Developments Table 190. Proteomics International Company Information Table 191. Proteomics International Business Overview Table 192. Proteomics International Revenue in Serum and Plasma Proteomics Service Business (2021-2026) & (US$ Million) Table 193. Proteomics International Serum and Plasma Proteomics Service Product Portfolio Table 194. Proteomics International Recent Developments Table 195. Proteome Sciences Company Information Table 196. Proteome Sciences Business Overview Table 197. Proteome Sciences Revenue in Serum and Plasma Proteomics Service Business (2021-2026) & (US$ Million) Table 198. Proteome Sciences Serum and Plasma Proteomics Service Product Portfolio Table 199. Proteome Sciences Recent Developments Table 200. Westlake Omics Company Information Table 201. Westlake Omics Business Overview Table 202. Westlake Omics Revenue in Serum and Plasma Proteomics Service Business (2021-2026) & (US$ Million) Table 203. Westlake Omics Serum and Plasma Proteomics Service Product Portfolio Table 204. Westlake Omics Recent Developments Table 205. Crown Bioscience Company Information Table 206. Crown Bioscience Business Overview Table 207. Crown Bioscience Revenue in Serum and Plasma Proteomics Service Business (2021-2026) & (US$ Million) Table 208. Crown Bioscience Serum and Plasma Proteomics Service Product Portfolio Table 209. Crown Bioscience Recent Developments Table 210. VProteomics Company Information Table 211. VProteomics Business Overview Table 212. VProteomics Revenue in Serum and Plasma Proteomics Service Business (2021-2026) & (US$ Million) Table 213. VProteomics Serum and Plasma Proteomics Service Product Portfolio Table 214. VProteomics Recent Developments Table 215. Shanghai Majorbio Bio-Pharm Company Information Table 216. Shanghai Majorbio Bio-Pharm Business Overview Table 217. Shanghai Majorbio Bio-Pharm Revenue in Serum and Plasma Proteomics Service Business (2021-2026) & (US$ Million) Table 218. Shanghai Majorbio Bio-Pharm Serum and Plasma Proteomics Service Product Portfolio Table 219. Shanghai Majorbio Bio-Pharm Recent Developments Table 220. Applied Biomics Company Information Table 221. Applied Biomics Business Overview Table 222. Applied Biomics Revenue in Serum and Plasma Proteomics Service Business (2021-2026) & (US$ Million) Table 223. Applied Biomics Serum and Plasma Proteomics Service Product Portfolio Table 224. Applied Biomics Recent Developments Table 225. Sapient Bioanalytics Company Information Table 226. Sapient Bioanalytics Business Overview Table 227. Sapient Bioanalytics Revenue in Serum and Plasma Proteomics Service Business (2021-2026) & (US$ Million) Table 228. Sapient Bioanalytics Serum and Plasma Proteomics Service Product Portfolio Table 229. Sapient Bioanalytics Recent Developments Table 230. Allumiqs Company Information Table 231. Allumiqs Business Overview Table 232. Allumiqs Revenue in Serum and Plasma Proteomics Service Business (2021-2026) & (US$ Million) Table 233. Allumiqs Serum and Plasma Proteomics Service Product Portfolio Table 234. Allumiqs Recent Developments Table 235. MS Bioworks Company Information Table 236. MS Bioworks Business Overview Table 237. MS Bioworks Revenue in Serum and Plasma Proteomics Service Business (2021-2026) & (US$ Million) Table 238. MS Bioworks Serum and Plasma Proteomics Service Product Portfolio Table 239. MS Bioworks Recent Developments Table 240. Shanghai Bioprofile Company Information Table 241. Shanghai Bioprofile Business Overview Table 242. Shanghai Bioprofile Revenue in Serum and Plasma Proteomics Service Business (2021-2026) & (US$ Million) Table 243. Shanghai Bioprofile Serum and Plasma Proteomics Service Product Portfolio Table 244. Shanghai Bioprofile Recent Developments Table 245. Cosmos Wisdom Company Information Table 246. Cosmos Wisdom Business Overview Table 247. Cosmos Wisdom Revenue in Serum and Plasma Proteomics Service Business (2021-2026) & (US$ Million) Table 248. Cosmos Wisdom Serum and Plasma Proteomics Service Product Portfolio Table 249. Cosmos Wisdom Recent Developments Table 250. Olink (Thermo Fisher Scientific) Company Information Table 251. Olink (Thermo Fisher Scientific) Business Overview Table 252. Olink (Thermo Fisher Scientific) Revenue in Serum and Plasma Proteomics Service Business (2021-2026) & (US$ Million) Table 253. Olink (Thermo Fisher Scientific) Serum and Plasma Proteomics Service Product Portfolio Table 254. Olink (Thermo Fisher Scientific) Recent Developments Table 255. SomaLogic (Illumina) Company Information Table 256. SomaLogic (Illumina) Business Overview Table 257. SomaLogic (Illumina) Revenue in Serum and Plasma Proteomics Service Business (2021-2026) & (US$ Million) Table 258. SomaLogic (Illumina) Serum and Plasma Proteomics Service Product Portfolio Table 259. SomaLogic (Illumina) Recent Developments Table 260. Labcorp Company Information Table 261. Labcorp Business Overview Table 262. Labcorp Revenue in Serum and Plasma Proteomics Service Business (2021-2026) & (US$ Million) Table 263. Labcorp Serum and Plasma Proteomics Service Product Portfolio Table 264. Labcorp Recent Developments Table 265. Authors List of This Report List of Figures Figure 1. Research Methodology Figure 2. Research Process Figure 3. Key Executives Interviewed Figure 4. Serum and Plasma Proteomics Service Product Image Figure 5. Global Serum and Plasma Proteomics Service Market Size Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 6. Global Serum and Plasma Proteomics Service Market Share by Type: 2025 VS 2032 Figure 7. Plasma Proteomics Analysis Service Product Figure 8. Serum Proteomics Analysis Service Product Figure 9. Global Serum and Plasma Proteomics Service Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 10. Global Serum and Plasma Proteomics Service Market Share by Application: 2025 VS 2032 Figure 11. Disease Biomarker Research Product Figure 12. Drug Development Product Figure 13. Clinical Research Product Figure 14. Others Product Figure 15. Global Serum and Plasma Proteomics Service Market Size (US$ Million), Year-over-Year: 2021-2032 Figure 16. Global Serum and Plasma Proteomics Service Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 17. Global Serum and Plasma Proteomics Service Market Share by Region: 2025 VS 2032 Figure 18. Global Serum and Plasma Proteomics Service Market Share by Players in 2025 Figure 19. Global Serum and Plasma Proteomics Service Manufacturers Established Date Figure 20. Global Top 5 and 10 Serum and Plasma Proteomics Service Players Market Share by Revenue in 2025 Figure 21. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 22. North America Serum and Plasma Proteomics Service Market Size YoY Growth (2021-2032) & (US$ Million) Figure 23. North America Serum and Plasma Proteomics Service Market Share by Country (2021-2032) Figure 24. United States Serum and Plasma Proteomics Service Market Size YoY Growth (2021-2032) & (US$ Million) Figure 25. Canada Serum and Plasma Proteomics Service Market Size YoY Growth (2021-2032) & (US$ Million) Figure 26. Mexico Serum and Plasma Proteomics Service Market Share by Country (2021-2032) Figure 27. Europe Serum and Plasma Proteomics Service Market Size YoY Growth (2021-2032) & (US$ Million) Figure 28. Europe Serum and Plasma Proteomics Service Market Share by Country (2021-2032) Figure 29. Germany Serum and Plasma Proteomics Service Market Size YoY Growth (2021-2032) & (US$ Million) Figure 30. France Serum and Plasma Proteomics Service Market Size YoY Growth (2021-2032) & (US$ Million) Figure 31. U.K. Serum and Plasma Proteomics Service Market Size YoY Growth (2021-2032) & (US$ Million) Figure 32. Italy Serum and Plasma Proteomics Service Market Size YoY Growth (2021-2032) & (US$ Million) Figure 33. Spain Serum and Plasma Proteomics Service Market Size YoY Growth (2021-2032) & (US$ Million) Figure 34. Russia Serum and Plasma Proteomics Service Market Size YoY Growth (2021-2032) & (US$ Million) Figure 35. Netherlands Serum and Plasma Proteomics Service Market Size YoY Growth (2021-2032) & (US$ Million) Figure 36. Nordic Countries Serum and Plasma Proteomics Service Market Size YoY Growth (2021-2032) & (US$ Million) Figure 37. Asia-Pacific Serum and Plasma Proteomics Service Market Size YoY Growth (2021-2032) & (US$ Million) Figure 38. Asia-Pacific Serum and Plasma Proteomics Service Market Share by Country (2021-2032) Figure 39. China Serum and Plasma Proteomics Service Market Size YoY Growth (2021-2032) & (US$ Million) Figure 40. Japan Serum and Plasma Proteomics Service Market Size YoY Growth (2021-2032) & (US$ Million) Figure 41. South Korea Serum and Plasma Proteomics Service Market Size YoY Growth (2021-2032) & (US$ Million) Figure 42. India Serum and Plasma Proteomics Service Market Size YoY Growth (2021-2032) & (US$ Million) Figure 43. India Serum and Plasma Proteomics Service Market Share by Country (2021-2032) Figure 44. Australia Serum and Plasma Proteomics Service Market Size YoY Growth (2021-2032) & (US$ Million) Figure 45. China Taiwan Serum and Plasma Proteomics Service Market Size YoY Growth (2021-2032) & (US$ Million) Figure 46. Southeast Asia Serum and Plasma Proteomics Service Market Size YoY Growth (2021-2032) & (US$ Million) Figure 47. South America Serum and Plasma Proteomics Service Market Size YoY Growth (2021-2032) & (US$ Million) Figure 48. South America Serum and Plasma Proteomics Service Market Share by Country (2021-2032) Figure 49. Brazil Serum and Plasma Proteomics Service Market Size YoY Growth (2021-2032) & (US$ Million) Figure 50. Argentina Serum and Plasma Proteomics Service Market Size YoY Growth (2021-2032) & (US$ Million) Figure 51. Chile Serum and Plasma Proteomics Service Market Size YoY Growth (2021-2032) & (US$ Million) Figure 52. Colombia Serum and Plasma Proteomics Service Market Size YoY Growth (2021-2032) & (US$ Million) Figure 53. Peru Serum and Plasma Proteomics Service Market Size YoY Growth (2021-2032) & (US$ Million) Figure 54. BostonGene Revenue Growth Rate in Serum and Plasma Proteomics Service Business (2021-2026) Figure 55. CellCarta Revenue Growth Rate in Serum and Plasma Proteomics Service Business (2021-2026) Figure 56. GENEWIZ (Azenta Life Sciences) Revenue Growth Rate in Serum and Plasma Proteomics Service Business (2021-2026) Figure 57. CDI Labs Revenue Growth Rate in Serum and Plasma Proteomics Service Business (2021-2026) Figure 58. Biognosys Revenue Growth Rate in Serum and Plasma Proteomics Service Business (2021-2026) Figure 59. Discovery Life Sciences Revenue Growth Rate in Serum and Plasma Proteomics Service Business (2021-2026) Figure 60. Firalis Molecular Precision Revenue Growth Rate in Serum and Plasma Proteomics Service Business (2021-2026) Figure 61. Cell Signaling Technology (CST) Revenue Growth Rate in Serum and Plasma Proteomics Service Business (2021-2026) Figure 62. Sampled (Infinity Biologix) Revenue Growth Rate in Serum and Plasma Proteomics Service Business (2021-2026) Figure 63. APTBIO Revenue Growth Rate in Serum and Plasma Proteomics Service Business (2021-2026) Figure 64. Sinotech Genomics Revenue Growth Rate in Serum and Plasma Proteomics Service Business (2021-2026) Figure 65. Biodesix Revenue Growth Rate in Serum and Plasma Proteomics Service Business (2021-2026) Figure 66. Panome Bio Revenue Growth Rate in Serum and Plasma Proteomics Service Business (2021-2026) Figure 67. Novogene Revenue Growth Rate in Serum and Plasma Proteomics Service Business (2021-2026) Figure 68. PTM BIO Revenue Growth Rate in Serum and Plasma Proteomics Service Business (2021-2026) Figure 69. BGI Genomics Revenue Growth Rate in Serum and Plasma Proteomics Service Business (2021-2026) Figure 70. Evotec Revenue Growth Rate in Serum and Plasma Proteomics Service Business (2021-2026) Figure 71. Metware Biotechnology Revenue Growth Rate in Serum and Plasma Proteomics Service Business (2021-2026) Figure 72. MRM Proteomics Revenue Growth Rate in Serum and Plasma Proteomics Service Business (2021-2026) Figure 73. Lc-Bio Technologies Revenue Growth Rate in Serum and Plasma Proteomics Service Business (2021-2026) Figure 74. Eurofins Scientific Revenue Growth Rate in Serum and Plasma Proteomics Service Business (2021-2026) Figure 75. MtoZ-Biolabs Revenue Growth Rate in Serum and Plasma Proteomics Service Business (2021-2026) Figure 76. Creative Proteomics Revenue Growth Rate in Serum and Plasma Proteomics Service Business (2021-2026) Figure 77. Macrogen Revenue Growth Rate in Serum and Plasma Proteomics Service Business (2021-2026) Figure 78. TATAA Biocenter Revenue Growth Rate in Serum and Plasma Proteomics Service Business (2021-2026) Figure 79. OmicScouts (Momentum Biotechnologies) Revenue Growth Rate in Serum and Plasma Proteomics Service Business (2021-2026) Figure 80. Precision Biomarker Laboratories (PBL) Revenue Growth Rate in Serum and Plasma Proteomics Service Business (2021-2026) Figure 81. Shanghai OE Biotech Revenue Growth Rate in Serum and Plasma Proteomics Service Business (2021-2026) Figure 82. RxCelerate Revenue Growth Rate in Serum and Plasma Proteomics Service Business (2021-2026) Figure 83. Proteomics International Revenue Growth Rate in Serum and Plasma Proteomics Service Business (2021-2026) Figure 84. Proteome Sciences Revenue Growth Rate in Serum and Plasma Proteomics Service Business (2021-2026) Figure 85. Westlake Omics Revenue Growth Rate in Serum and Plasma Proteomics Service Business (2021-2026) Figure 86. Crown Bioscience Revenue Growth Rate in Serum and Plasma Proteomics Service Business (2021-2026) Figure 87. VProteomics Revenue Growth Rate in Serum and Plasma Proteomics Service Business (2021-2026) Figure 88. Shanghai Majorbio Bio-Pharm Revenue Growth Rate in Serum and Plasma Proteomics Service Business (2021-2026) Figure 89. Applied Biomics Revenue Growth Rate in Serum and Plasma Proteomics Service Business (2021-2026) Figure 90. Sapient Bioanalytics Revenue Growth Rate in Serum and Plasma Proteomics Service Business (2021-2026) Figure 91. Allumiqs Revenue Growth Rate in Serum and Plasma Proteomics Service Business (2021-2026) Figure 92. MS Bioworks Revenue Growth Rate in Serum and Plasma Proteomics Service Business (2021-2026) Figure 93. Shanghai Bioprofile Revenue Growth Rate in Serum and Plasma Proteomics Service Business (2021-2026) Figure 94. Cosmos Wisdom Revenue Growth Rate in Serum and Plasma Proteomics Service Business (2021-2026) Figure 95. Olink (Thermo Fisher Scientific) Revenue Growth Rate in Serum and Plasma Proteomics Service Business (2021-2026) Figure 96. SomaLogic (Illumina) Revenue Growth Rate in Serum and Plasma Proteomics Service Business (2021-2026) Figure 97. Labcorp Revenue Growth Rate in Serum and Plasma Proteomics Service Business (2021-2026)

Scope & coverage.

Types
  • Plasma Proteomics Analysis Service
  • Serum Proteomics Analysis Service
Applications
  • Disease Biomarker Research
  • Drug Development
  • Clinical Research
  • Others
Companies covered
  • BostonGene
  • CellCarta
  • GENEWIZ (Azenta Life Sciences)
  • CDI Labs
  • Biognosys
  • Discovery Life Sciences
  • Firalis Molecular Precision
  • Cell Signaling Technology (CST)
  • Sampled (Infinity Biologix)
  • APTBIO
  • Sinotech Genomics
  • Biodesix
  • Panome Bio
  • Novogene
  • PTM BIO
  • BGI Genomics
  • Evotec
  • Metware Biotechnology
  • MRM Proteomics
  • Lc-Bio Technologies
  • Eurofins Scientific
  • MtoZ-Biolabs
  • Creative Proteomics
  • Macrogen
  • TATAA Biocenter
  • OmicScouts (Momentum Biotechnologies)
  • Precision Biomarker Laboratories (PBL)
  • Shanghai OE Biotech
  • RxCelerate
  • Proteomics International
  • Proteome Sciences
  • Westlake Omics
  • Crown Bioscience
  • VProteomics
  • Shanghai Majorbio Bio-Pharm
  • Applied Biomics
  • Sapient Bioanalytics
  • Allumiqs
  • MS Bioworks
  • Shanghai Bioprofile
  • Cosmos Wisdom
  • Olink (Thermo Fisher Scientific)
  • SomaLogic (Illumina)
  • Labcorp

Inside the report.

1 Preface
  1. 1.1 Scope of Report
  2. 1.2 Reasons for Doing This Study
  3. 1.3 Research Methodology
  4. 1.4 Research Process
  5. 1.5 Data Source
  6. 1.5.1 Secondary Sources
  7. 1.5.2 Primary Sources
2 Market Overview
  1. 2.1 Product Definition
  2. 2.2 Serum and Plasma Proteomics Service by Type
  3. 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
  4. 2.2.2 Plasma Proteomics Analysis Service
  5. 2.2.3 Serum Proteomics Analysis Service
  6. 2.3 Serum and Plasma Proteomics Service by Application
  7. 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
  8. 2.3.2 Disease Biomarker Research
  9. 2.3.3 Drug Development
  10. 2.3.4 Clinical Research
  11. 2.3.5 Others
  12. 2.4 Assumptions and Limitations
3 Serum and Plasma Proteomics Service Breakdown Data by Type
  1. 3.1 Global Serum and Plasma Proteomics Service Historic Market Size by Type (2021-2026)
  2. 3.2 Global Serum and Plasma Proteomics Service Forecasted Market Size by Type (2027-2032)
4 Serum and Plasma Proteomics Service Breakdown Data by Application
  1. 4.1 Global Serum and Plasma Proteomics Service Historic Market Size by Application (2021-2026)
  2. 4.2 Global Serum and Plasma Proteomics Service Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
  1. 5.1 Global Serum and Plasma Proteomics Service Market Perspective (2021-2032)
  2. 5.2 Global Serum and Plasma Proteomics Service Growth Trends by Region
  3. 5.2.1 Global Serum and Plasma Proteomics Service Market Size by Region: 2021 VS 2025 VS 2032
  4. 5.2.2 Serum and Plasma Proteomics Service Historic Market Size by Region (2021-2026)
  5. 5.2.3 Serum and Plasma Proteomics Service Forecasted Market Size by Region (2027-2032)
  6. 5.3 Serum and Plasma Proteomics Service Market Dynamics
  7. 5.3.1 Serum and Plasma Proteomics Service Industry Trends
  8. 5.3.2 Serum and Plasma Proteomics Service Market Drivers
  9. 5.3.3 Serum and Plasma Proteomics Service Market Challenges
  10. 5.3.4 Serum and Plasma Proteomics Service Market Restraints
6 Market Competitive Landscape by Players
  1. 6.1 Global Top Serum and Plasma Proteomics Service Players by Revenue
  2. 6.1.1 Global Top Serum and Plasma Proteomics Service Players by Revenue (2021-2026)
  3. 6.1.2 Global Serum and Plasma Proteomics Service Revenue Market Share by Players (2021-2026)
  4. 6.2 Global Serum and Plasma Proteomics Service Industry Players Ranking, 2023 VS 2024 VS 2025
  5. 6.3 Global Key Players of Serum and Plasma Proteomics Service Head Office and Area Served
  6. 6.4 Global Serum and Plasma Proteomics Service Players, Product Type & Application
  7. 6.5 Global Serum and Plasma Proteomics Service Manufacturers Established Date
  8. 6.6 Global Serum and Plasma Proteomics Service Market CR5 and HHI
  9. 6.7 Global Players Mergers & Acquisition
7 North America
  1. 7.1 North America Serum and Plasma Proteomics Service Market Size (2021-2032)
  2. 7.2 North America Serum and Plasma Proteomics Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
  3. 7.3 North America Serum and Plasma Proteomics Service Market Size by Country (2021-2026)
  4. 7.4 North America Serum and Plasma Proteomics Service Market Size by Country (2027-2032)
  5. 7.5 United States
  6. 7.5 United States
  7. 7.6 Canada
  8. 7.7 Mexico
8 Europe
  1. 8.1 Europe Serum and Plasma Proteomics Service Market Size (2021-2032)
  2. 8.2 Europe Serum and Plasma Proteomics Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
  3. 8.3 Europe Serum and Plasma Proteomics Service Market Size by Country (2021-2026)
  4. 8.4 Europe Serum and Plasma Proteomics Service Market Size by Country (2027-2032)
  5. 8.5 Germany
  6. 8.6 France
  7. 8.7 U.K.
  8. 8.8 Italy
  9. 8.9 Spain
  10. 8.10 Russia
  11. 8.11 Netherlands
  12. 8.12 Nordic Countries
9 Asia-Pacific
  1. 9.1 Asia-Pacific Serum and Plasma Proteomics Service Market Size (2021-2032)
  2. 9.2 Asia-Pacific Serum and Plasma Proteomics Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
  3. 9.3 Asia-Pacific Serum and Plasma Proteomics Service Market Size by Country (2021-2026)
  4. 9.4 Asia-Pacific Serum and Plasma Proteomics Service Market Size by Country (2027-2032)
  5. 9.5 China
  6. 9.6 Japan
  7. 9.7 South Korea
  8. 9.8 India
  9. 9.9 Australia
  10. 9.10 China Taiwan
  11. 9.11 Southeast Asia
10 South America
  1. 10.1 South America Serum and Plasma Proteomics Service Market Size (2021-2032)
  2. 10.2 South America Serum and Plasma Proteomics Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
  3. 10.3 South America Serum and Plasma Proteomics Service Market Size by Country (2021-2026)
  4. 10.4 South America Serum and Plasma Proteomics Service Market Size by Country (2027-2032)
  5. 10.5 Brazil
  6. 10.6 Argentina
  7. 10.7 Chile
  8. 10.8 Colombia
  9. 10.9 Peru
11 Middle East & Africa
  1. 11.1 Middle East & Africa Serum and Plasma Proteomics Service Market Size (2021-2032)
  2. 11.2 Middle East & Africa Serum and Plasma Proteomics Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
  3. 11.3 Middle East & Africa Serum and Plasma Proteomics Service Market Size by Country (2021-2026)
  4. 11.4 Middle East & Africa Serum and Plasma Proteomics Service Market Size by Country (2027-2032)
  5. 11.5 Saudi Arabia
  6. 11.6 Israel
  7. 11.7 United Arab Emirates
  8. 11.8 Turkey
  9. 11.9 Iran
  10. 11.10 Egypt
12 Players Profiled
  1. 12.1 BostonGene
  2. 12.1.1 BostonGene Company Information
  3. 12.1.2 BostonGene Business Overview
  4. 12.1.3 BostonGene Revenue in Serum and Plasma Proteomics Service Business (2021-2026)
  5. 12.1.4 BostonGene Serum and Plasma Proteomics Service Product Portfolio
  6. 12.1.5 BostonGene Recent Developments
  7. 12.2 CellCarta
  8. 12.2.1 CellCarta Company Information
  9. 12.2.2 CellCarta Business Overview
  10. 12.2.3 CellCarta Revenue in Serum and Plasma Proteomics Service Business (2021-2026)
  11. 12.2.4 CellCarta Serum and Plasma Proteomics Service Product Portfolio
  12. 12.2.5 CellCarta Recent Developments
  13. 12.3 GENEWIZ (Azenta Life Sciences)
  14. 12.3.1 GENEWIZ (Azenta Life Sciences) Company Information
  15. 12.3.2 GENEWIZ (Azenta Life Sciences) Business Overview
  16. 12.3.3 GENEWIZ (Azenta Life Sciences) Revenue in Serum and Plasma Proteomics Service Business (2021-2026)
  17. 12.3.4 GENEWIZ (Azenta Life Sciences) Serum and Plasma Proteomics Service Product Portfolio
  18. 12.3.5 GENEWIZ (Azenta Life Sciences) Recent Developments
  19. 12.4 CDI Labs
  20. 12.4.1 CDI Labs Company Information
  21. 12.4.2 CDI Labs Business Overview
  22. 12.4.3 CDI Labs Revenue in Serum and Plasma Proteomics Service Business (2021-2026)
  23. 12.4.4 CDI Labs Serum and Plasma Proteomics Service Product Portfolio
  24. 12.4.5 CDI Labs Recent Developments
  25. 12.5 Biognosys
  26. 12.5.1 Biognosys Company Information
  27. 12.5.2 Biognosys Business Overview
  28. 12.5.3 Biognosys Revenue in Serum and Plasma Proteomics Service Business (2021-2026)
  29. 12.5.4 Biognosys Serum and Plasma Proteomics Service Product Portfolio
  30. 12.5.5 Biognosys Recent Developments
  31. 12.6 Discovery Life Sciences
  32. 12.6.1 Discovery Life Sciences Company Information
  33. 12.6.2 Discovery Life Sciences Business Overview
  34. 12.6.3 Discovery Life Sciences Revenue in Serum and Plasma Proteomics Service Business (2021-2026)
  35. 12.6.4 Discovery Life Sciences Serum and Plasma Proteomics Service Product Portfolio
  36. 12.6.5 Discovery Life Sciences Recent Developments
  37. 12.7 Firalis Molecular Precision
  38. 12.7.1 Firalis Molecular Precision Company Information
  39. 12.7.2 Firalis Molecular Precision Business Overview
  40. 12.7.3 Firalis Molecular Precision Revenue in Serum and Plasma Proteomics Service Business (2021-2026)
  41. 12.7.4 Firalis Molecular Precision Serum and Plasma Proteomics Service Product Portfolio
  42. 12.7.5 Firalis Molecular Precision Recent Developments
  43. 12.8 Cell Signaling Technology (CST)
  44. 12.8.1 Cell Signaling Technology (CST) Company Information
  45. 12.8.2 Cell Signaling Technology (CST) Business Overview
  46. 12.8.3 Cell Signaling Technology (CST) Revenue in Serum and Plasma Proteomics Service Business (2021-2026)
  47. 12.8.4 Cell Signaling Technology (CST) Serum and Plasma Proteomics Service Product Portfolio
  48. 12.8.5 Cell Signaling Technology (CST) Recent Developments
  49. 12.9 Sampled (Infinity Biologix)
  50. 12.9.1 Sampled (Infinity Biologix) Company Information
  51. 12.9.2 Sampled (Infinity Biologix) Business Overview
  52. 12.9.3 Sampled (Infinity Biologix) Revenue in Serum and Plasma Proteomics Service Business (2021-2026)
  53. 12.9.4 Sampled (Infinity Biologix) Serum and Plasma Proteomics Service Product Portfolio
  54. 12.9.5 Sampled (Infinity Biologix) Recent Developments
  55. 12.10 APTBIO
  56. 12.10.1 APTBIO Company Information
  57. 12.10.2 APTBIO Business Overview
  58. 12.10.3 APTBIO Revenue in Serum and Plasma Proteomics Service Business (2021-2026)
  59. 12.10.4 APTBIO Serum and Plasma Proteomics Service Product Portfolio
  60. 12.10.5 APTBIO Recent Developments
  61. 12.11 Sinotech Genomics
  62. 12.11.1 Sinotech Genomics Company Information
  63. 12.11.2 Sinotech Genomics Business Overview
  64. 12.11.3 Sinotech Genomics Revenue in Serum and Plasma Proteomics Service Business (2021-2026)
  65. 12.11.4 Sinotech Genomics Serum and Plasma Proteomics Service Product Portfolio
  66. 12.11.5 Sinotech Genomics Recent Developments
  67. 12.12 Biodesix
  68. 12.12.1 Biodesix Company Information
  69. 12.12.2 Biodesix Business Overview
  70. 12.12.3 Biodesix Revenue in Serum and Plasma Proteomics Service Business (2021-2026)
  71. 12.12.4 Biodesix Serum and Plasma Proteomics Service Product Portfolio
  72. 12.12.5 Biodesix Recent Developments
  73. 12.13 Panome Bio
  74. 12.13.1 Panome Bio Company Information
  75. 12.13.2 Panome Bio Business Overview
  76. 12.13.3 Panome Bio Revenue in Serum and Plasma Proteomics Service Business (2021-2026)
  77. 12.13.4 Panome Bio Serum and Plasma Proteomics Service Product Portfolio
  78. 12.13.5 Panome Bio Recent Developments
  79. 12.14 Novogene
  80. 12.14.1 Novogene Company Information
  81. 12.14.2 Novogene Business Overview
  82. 12.14.3 Novogene Revenue in Serum and Plasma Proteomics Service Business (2021-2026)
  83. 12.14.4 Novogene Serum and Plasma Proteomics Service Product Portfolio
  84. 12.14.5 Novogene Recent Developments
  85. 12.15 PTM BIO
  86. 12.15.1 PTM BIO Company Information
  87. 12.15.2 PTM BIO Business Overview
  88. 12.15.3 PTM BIO Revenue in Serum and Plasma Proteomics Service Business (2021-2026)
  89. 12.15.4 PTM BIO Serum and Plasma Proteomics Service Product Portfolio
  90. 12.15.5 PTM BIO Recent Developments
  91. 12.16 BGI Genomics
  92. 12.16.1 BGI Genomics Company Information
  93. 12.16.2 BGI Genomics Business Overview
  94. 12.16.3 BGI Genomics Revenue in Serum and Plasma Proteomics Service Business (2021-2026)
  95. 12.16.4 BGI Genomics Serum and Plasma Proteomics Service Product Portfolio
  96. 12.16.5 BGI Genomics Recent Developments
  97. 12.17 Evotec
  98. 12.17.1 Evotec Company Information
  99. 12.17.2 Evotec Business Overview
  100. 12.17.3 Evotec Revenue in Serum and Plasma Proteomics Service Business (2021-2026)
  101. 12.17.4 Evotec Serum and Plasma Proteomics Service Product Portfolio
  102. 12.17.5 Evotec Recent Developments
  103. 12.18 Metware Biotechnology
  104. 12.18.1 Metware Biotechnology Company Information
  105. 12.18.2 Metware Biotechnology Business Overview
  106. 12.18.3 Metware Biotechnology Revenue in Serum and Plasma Proteomics Service Business (2021-2026)
  107. 12.18.4 Metware Biotechnology Serum and Plasma Proteomics Service Product Portfolio
  108. 12.18.5 Metware Biotechnology Recent Developments
  109. 12.19 MRM Proteomics
  110. 12.19.1 MRM Proteomics Company Information
  111. 12.19.2 MRM Proteomics Business Overview
  112. 12.19.3 MRM Proteomics Revenue in Serum and Plasma Proteomics Service Business (2021-2026)
  113. 12.19.4 MRM Proteomics Serum and Plasma Proteomics Service Product Portfolio
  114. 12.19.5 MRM Proteomics Recent Developments
  115. 12.20 Lc-Bio Technologies
  116. 12.20.1 Lc-Bio Technologies Company Information
  117. 12.20.2 Lc-Bio Technologies Business Overview
  118. 12.20.3 Lc-Bio Technologies Revenue in Serum and Plasma Proteomics Service Business (2021-2026)
  119. 12.20.4 Lc-Bio Technologies Serum and Plasma Proteomics Service Product Portfolio
  120. 12.20.5 Lc-Bio Technologies Recent Developments
  121. 12.21 Eurofins Scientific
  122. 12.21.1 Eurofins Scientific Company Information
  123. 12.21.2 Eurofins Scientific Business Overview
  124. 12.21.3 Eurofins Scientific Revenue in Serum and Plasma Proteomics Service Business (2021-2026)
  125. 12.21.4 Eurofins Scientific Serum and Plasma Proteomics Service Product Portfolio
  126. 12.21.5 Eurofins Scientific Recent Developments
  127. 12.22 MtoZ-Biolabs
  128. 12.22.1 MtoZ-Biolabs Company Information
  129. 12.22.2 MtoZ-Biolabs Business Overview
  130. 12.22.3 MtoZ-Biolabs Revenue in Serum and Plasma Proteomics Service Business (2021-2026)
  131. 12.22.4 MtoZ-Biolabs Serum and Plasma Proteomics Service Product Portfolio
  132. 12.22.5 MtoZ-Biolabs Recent Developments
  133. 12.23 Creative Proteomics
  134. 12.23.1 Creative Proteomics Company Information
  135. 12.23.2 Creative Proteomics Business Overview
  136. 12.23.3 Creative Proteomics Revenue in Serum and Plasma Proteomics Service Business (2021-2026)
  137. 12.23.4 Creative Proteomics Serum and Plasma Proteomics Service Product Portfolio
  138. 12.23.5 Creative Proteomics Recent Developments
  139. 12.24 Macrogen
  140. 12.24.1 Macrogen Company Information
  141. 12.24.2 Macrogen Business Overview
  142. 12.24.3 Macrogen Revenue in Serum and Plasma Proteomics Service Business (2021-2026)
  143. 12.24.4 Macrogen Serum and Plasma Proteomics Service Product Portfolio
  144. 12.24.5 Macrogen Recent Developments
  145. 12.25 TATAA Biocenter
  146. 12.25.1 TATAA Biocenter Company Information
  147. 12.25.2 TATAA Biocenter Business Overview
  148. 12.25.3 TATAA Biocenter Revenue in Serum and Plasma Proteomics Service Business (2021-2026)
  149. 12.25.4 TATAA Biocenter Serum and Plasma Proteomics Service Product Portfolio
  150. 12.25.5 TATAA Biocenter Recent Developments
  151. 12.26 OmicScouts (Momentum Biotechnologies)
  152. 12.26.1 OmicScouts (Momentum Biotechnologies) Company Information
  153. 12.26.2 OmicScouts (Momentum Biotechnologies) Business Overview
  154. 12.26.3 OmicScouts (Momentum Biotechnologies) Revenue in Serum and Plasma Proteomics Service Business (2021-2026)
  155. 12.26.4 OmicScouts (Momentum Biotechnologies) Serum and Plasma Proteomics Service Product Portfolio
  156. 12.26.5 OmicScouts (Momentum Biotechnologies) Recent Developments
  157. 12.27 Precision Biomarker Laboratories (PBL)
  158. 12.27.1 Precision Biomarker Laboratories (PBL) Company Information
  159. 12.27.2 Precision Biomarker Laboratories (PBL) Business Overview
  160. 12.27.3 Precision Biomarker Laboratories (PBL) Revenue in Serum and Plasma Proteomics Service Business (2021-2026)
  161. 12.27.4 Precision Biomarker Laboratories (PBL) Serum and Plasma Proteomics Service Product Portfolio
  162. 12.27.5 Precision Biomarker Laboratories (PBL) Recent Developments
  163. 12.28 Shanghai OE Biotech
  164. 12.28.1 Shanghai OE Biotech Company Information
  165. 12.28.2 Shanghai OE Biotech Business Overview
  166. 12.28.3 Shanghai OE Biotech Revenue in Serum and Plasma Proteomics Service Business (2021-2026)
  167. 12.28.4 Shanghai OE Biotech Serum and Plasma Proteomics Service Product Portfolio
  168. 12.28.5 Shanghai OE Biotech Recent Developments
  169. 12.29 RxCelerate
  170. 12.29.1 RxCelerate Company Information
  171. 12.29.2 RxCelerate Business Overview
  172. 12.29.3 RxCelerate Revenue in Serum and Plasma Proteomics Service Business (2021-2026)
  173. 12.29.4 RxCelerate Serum and Plasma Proteomics Service Product Portfolio
  174. 12.29.5 RxCelerate Recent Developments
  175. 12.30 Proteomics International
  176. 12.30.1 Proteomics International Company Information
  177. 12.30.2 Proteomics International Business Overview
  178. 12.30.3 Proteomics International Revenue in Serum and Plasma Proteomics Service Business (2021-2026)
  179. 12.30.4 Proteomics International Serum and Plasma Proteomics Service Product Portfolio
  180. 12.30.5 Proteomics International Recent Developments
  181. 12.31 Proteome Sciences
  182. 12.31.1 Proteome Sciences Company Information
  183. 12.31.2 Proteome Sciences Business Overview
  184. 12.31.3 Proteome Sciences Revenue in Serum and Plasma Proteomics Service Business (2021-2026)
  185. 12.31.4 Proteome Sciences Serum and Plasma Proteomics Service Product Portfolio
  186. 12.31.5 Proteome Sciences Recent Developments
  187. 12.32 Westlake Omics
  188. 12.32.1 Westlake Omics Company Information
  189. 12.32.2 Westlake Omics Business Overview
  190. 12.32.3 Westlake Omics Revenue in Serum and Plasma Proteomics Service Business (2021-2026)
  191. 12.32.4 Westlake Omics Serum and Plasma Proteomics Service Product Portfolio
  192. 12.32.5 Westlake Omics Recent Developments
  193. 12.33 Crown Bioscience
  194. 12.33.1 Crown Bioscience Company Information
  195. 12.33.2 Crown Bioscience Business Overview
  196. 12.33.3 Crown Bioscience Revenue in Serum and Plasma Proteomics Service Business (2021-2026)
  197. 12.33.4 Crown Bioscience Serum and Plasma Proteomics Service Product Portfolio
  198. 12.33.5 Crown Bioscience Recent Developments
  199. 12.34 VProteomics
  200. 12.34.1 VProteomics Company Information
  201. 12.34.2 VProteomics Business Overview
  202. 12.34.3 VProteomics Revenue in Serum and Plasma Proteomics Service Business (2021-2026)
  203. 12.34.4 VProteomics Serum and Plasma Proteomics Service Product Portfolio
  204. 12.34.5 VProteomics Recent Developments
  205. 12.35 Shanghai Majorbio Bio-Pharm
  206. 12.35.1 Shanghai Majorbio Bio-Pharm Company Information
  207. 12.35.2 Shanghai Majorbio Bio-Pharm Business Overview
  208. 12.35.3 Shanghai Majorbio Bio-Pharm Revenue in Serum and Plasma Proteomics Service Business (2021-2026)
  209. 12.35.4 Shanghai Majorbio Bio-Pharm Serum and Plasma Proteomics Service Product Portfolio
  210. 12.35.5 Shanghai Majorbio Bio-Pharm Recent Developments
  211. 12.36 Applied Biomics
  212. 12.36.1 Applied Biomics Company Information
  213. 12.36.2 Applied Biomics Business Overview
  214. 12.36.3 Applied Biomics Revenue in Serum and Plasma Proteomics Service Business (2021-2026)
  215. 12.36.4 Applied Biomics Serum and Plasma Proteomics Service Product Portfolio
  216. 12.36.5 Applied Biomics Recent Developments
  217. 12.37 Sapient Bioanalytics
  218. 12.37.1 Sapient Bioanalytics Company Information
  219. 12.37.2 Sapient Bioanalytics Business Overview
  220. 12.37.3 Sapient Bioanalytics Revenue in Serum and Plasma Proteomics Service Business (2021-2026)
  221. 12.37.4 Sapient Bioanalytics Serum and Plasma Proteomics Service Product Portfolio
  222. 12.37.5 Sapient Bioanalytics Recent Developments
  223. 12.38 Allumiqs
  224. 12.38.1 Allumiqs Company Information
  225. 12.38.2 Allumiqs Business Overview
  226. 12.38.3 Allumiqs Revenue in Serum and Plasma Proteomics Service Business (2021-2026)
  227. 12.38.4 Allumiqs Serum and Plasma Proteomics Service Product Portfolio
  228. 12.38.5 Allumiqs Recent Developments
  229. 12.39 MS Bioworks
  230. 12.39.1 MS Bioworks Company Information
  231. 12.39.2 MS Bioworks Business Overview
  232. 12.39.3 MS Bioworks Revenue in Serum and Plasma Proteomics Service Business (2021-2026)
  233. 12.39.4 MS Bioworks Serum and Plasma Proteomics Service Product Portfolio
  234. 12.39.5 MS Bioworks Recent Developments
  235. 12.40 Shanghai Bioprofile
  236. 12.40.1 Shanghai Bioprofile Company Information
  237. 12.40.2 Shanghai Bioprofile Business Overview
  238. 12.40.3 Shanghai Bioprofile Revenue in Serum and Plasma Proteomics Service Business (2021-2026)
  239. 12.40.4 Shanghai Bioprofile Serum and Plasma Proteomics Service Product Portfolio
  240. 12.40.5 Shanghai Bioprofile Recent Developments
  241. 12.41 Cosmos Wisdom
  242. 12.41.1 Cosmos Wisdom Company Information
  243. 12.41.2 Cosmos Wisdom Business Overview
  244. 12.41.3 Cosmos Wisdom Revenue in Serum and Plasma Proteomics Service Business (2021-2026)
  245. 12.41.4 Cosmos Wisdom Serum and Plasma Proteomics Service Product Portfolio
  246. 12.41.5 Cosmos Wisdom Recent Developments
  247. 12.42 Olink (Thermo Fisher Scientific)
  248. 12.42.1 Olink (Thermo Fisher Scientific) Company Information
  249. 12.42.2 Olink (Thermo Fisher Scientific) Business Overview
  250. 12.42.3 Olink (Thermo Fisher Scientific) Revenue in Serum and Plasma Proteomics Service Business (2021-2026)
  251. 12.42.4 Olink (Thermo Fisher Scientific) Serum and Plasma Proteomics Service Product Portfolio
  252. 12.42.5 Olink (Thermo Fisher Scientific) Recent Developments
  253. 12.43 SomaLogic (Illumina)
  254. 12.43.1 SomaLogic (Illumina) Company Information
  255. 12.43.2 SomaLogic (Illumina) Business Overview
  256. 12.43.3 SomaLogic (Illumina) Revenue in Serum and Plasma Proteomics Service Business (2021-2026)
  257. 12.43.4 SomaLogic (Illumina) Serum and Plasma Proteomics Service Product Portfolio
  258. 12.43.5 SomaLogic (Illumina) Recent Developments
  259. 12.44 Labcorp
  260. 12.44.1 Labcorp Company Information
  261. 12.44.2 Labcorp Business Overview
  262. 12.44.3 Labcorp Revenue in Serum and Plasma Proteomics Service Business (2021-2026)
  263. 12.44.4 Labcorp Serum and Plasma Proteomics Service Product Portfolio
  264. 12.44.5 Labcorp Recent Developments
13 Report Conclusion
    14 Disclaimer

      GET THE RESEARCH

      Choose your license.

      Choose who needs access.
      All options are for this report and research series.

      Compare access permissions.

      Single User License
      One named user. Individual access.
      Multi User License
      Up to 5 users in the same department.
      Enterprise License
      Organization-wide access within the agreed license.

      Access applies to the purchased edition. Later editions are separate purchases.

      License options
      $2,950USD
      Buy now

      PDF by email within 3–5 working days after payment confirmation.

      Talk to an analyst
      APO Research
      Talk to an analyst